Patents by Inventor Yoshikazu Goto
Yoshikazu Goto has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230313745Abstract: An intake system of an internal combustion engine, in which a phase angle between throttle valves is provided in order to perform combustion appropriate for each cylinder so as to stabilize a number of revolutions and thereby suppress generation of unburned gas, is provided. The intake system is provided to intake passages of an internal combustion engine with parallel cylinders. The intake system includes a power transmission mechanism configured to transmit power from a power source to throttle shafts so as to synchronize and simultaneously turn a plurality of throttle valves and thereby open and close the intake passages. At least one of the throttle valves is an angled throttle valve having a phase angle at an open position relative to the other throttle valve.Type: ApplicationFiled: March 22, 2023Publication date: October 5, 2023Applicant: Honda Motor Co., Ltd.Inventors: Jun NAKANO, Noriyuki SUZUKI, Akihiko MATSUKAWA, Yoshikazu GOTO, Kenichi SANO, Akihiro KANOE, Takeo KATO
-
Publication number: 20220089532Abstract: A compound represented by general formula (I) (in the formula, all symbols are as described in the description) or a salt thereof has a potent nerve-protecting and/or -repairing activity, and therefore can be used as a therapeutic agent for neuropathy (e.g., chronic inflammatory demyelinating polyneuropathy, Guillain-Barre syndrome, periarteritis nodosa, allergic vasculitis, diabetic peripheral neuropathy, entrapment neuropathy, peripheral neuropathy associated with the administration of a chemotherapeutic drug, or peripheral neuropathy associated with Charcot-Marie-Tooth disease).Type: ApplicationFiled: December 7, 2021Publication date: March 24, 2022Applicant: ONO PHARMACEUTICAL CO., LTD.Inventors: Shoji NOJIMA, Kenji SASAKI, Tohru KAMBE, Takashi KONEMURA, Yoshikazu GOTO
-
Patent number: 11261154Abstract: A compound represented by general formula (I) (in the formula, all symbols are as described in the description) or a salt thereof has a potent nerve-protecting and/or -repairing activity, and therefore can be used as a therapeutic agent for neuropathy (e.g., chronic inflammatory demyelinating polyneuropathy, Guillain-Barre syndrome, periarteritis nodosa, allergic vasculitis, diabetic peripheral neuropathy, entrapment neuropathy, peripheral neuropathy associated with the administration of a chemotherapeutic drug, or peripheral neuropathy associated with Charcot-Marie-Tooth disease).Type: GrantFiled: July 30, 2019Date of Patent: March 1, 2022Assignee: ONO PHARMACEUTICAL CO., LTD.Inventors: Shoji Nojima, Kenji Sasaki, Tohru Kambe, Takashi Konemura, Yoshikazu Goto
-
Patent number: 11184411Abstract: A communication terminal that receives at least one of image data and audio data from at least one other communication terminal via a network, the communication terminal including circuitry to generate log data in response to occurrence of an event at the communication terminal, and transmit the generated log data to an accumulation apparatus each time the event occurs.Type: GrantFiled: July 31, 2019Date of Patent: November 23, 2021Assignee: Ricoh Company, Ltd.Inventors: Kazuhiro Terayama, Kenichiro Morita, Tatsuya Nagase, Takashi Hasegawa, Shoichiro Kanematsu, Yoshikazu Goto
-
Publication number: 20210332009Abstract: A compound represented by general formula (I) (in the formula, all symbols are as described in the description) or a salt thereof has a potent nerve-protecting and/or -repairing activity, and therefore can be used as a therapeutic agent for neuropathy (e.g., chronic inflammatory demyelinating polyneuropathy, Guillain-Barre syndrome, periarteritis nodosa, allergic vasculitis, diabetic peripheral neuropathy, entrapment neuropathy, peripheral neuropathy associated with the administration of a chemotherapeutic drug, or peripheral neuropathy associated with Charcot-Marie-Tooth disease).Type: ApplicationFiled: July 30, 2019Publication date: October 28, 2021Applicant: ONO PHARMACEUTICAL CO., LTD.Inventors: Shoji NOJIMA, Kenji SASAKI, Tohru KAMBE, Takashi KONEMURA, Yoshikazu GOTO
-
Publication number: 20200067992Abstract: A communication terminal that receives at least one of image data and audio data from at least one other communication terminal via a network, the communication terminal including circuitry to generate log data in response to occurrence of an event at the communication terminal, and transmit the generated log data to an accumulation apparatus each time the event occurs.Type: ApplicationFiled: July 31, 2019Publication date: February 27, 2020Applicant: Ricoh Company, Ltd.Inventors: KAZUHIRO TERAYAMA, KENICHIRO MORITA, TATSUYA NAGASE, TAKASHI HASEGAWA, SHOICHIRO KANEMATSU, YOSHIKAZU GOTO
-
Patent number: 10385045Abstract: Provided is an EP2 agonist having excellent safety. A compound represented by general formula (I) (wherein all symbols are as defined in the description), a salt or N-oxide of the compound, or a solvate or prodrug of the compound or the salt or N-oxide has an EP2 agonist activity and is highly safe, and is therefore useful as a medicine, particularly a therapeutic agent for diseases associated with EP2 receptors, such as immune diseases, allergic diseases, neuronal death, dysmenorrhea, premature birth, miscarriage, baldness, ocular diseases, erectile dysfunction, arthritis, lung injury, pulmonary fibrosis, pulmonary emphysema, bronchitis, chronic obstructive pulmonary disease, bone diseases and cartilage injury.Type: GrantFiled: July 22, 2016Date of Patent: August 20, 2019Assignee: ONO PHARMACEUTICAL CO., LTD.Inventors: Seiji Ogawa, Toshihide Watanabe, Isamu Sugimoto, Kousuke Tani, Kazumi Moriyuki, Yoshikazu Goto, Shinsaku Yamane
-
Publication number: 20180215747Abstract: Provided is an EP2 agonist having excellent safety. A compound represented by general formula (I) (wherein all symbols are as defined in the description), a salt or N-oxide of the compound, or a solvate or prodrug of the compound or the salt or N-oxide has an EP2 agonist activity and is highly safe, and is therefore useful as a medicine, particularly a therapeutic agent for diseases associated with EP2 receptors, such as immune diseases, allergic diseases, neuronal death, dysmenorrhea, premature birth, miscarriage, baldness, ocular diseases, erectile dysfunction, arthritis, lung injury, pulmonary fibrosis, pulmonary emphysema, bronchitis, chronic obstructive pulmonary disease, bone diseases and cartilage injury.Type: ApplicationFiled: July 22, 2016Publication date: August 2, 2018Applicant: ONO Pharmaceutical Co., Ltd.Inventors: Seiji OGAWA, Toshihide WATANABE, Isamu SUGIMOTO, Kousuke TANI, Kazumi MORIYUKI, Yoshikazu GOTO, Shinsaku YAMANE
-
Patent number: 10021345Abstract: A communication management system transmits questionnaire information including a set of questions relating to one or more services available to a communication terminal to the communication terminal through a network, receives answer information including a set of answers to the set of questions from the communication terminal through the network, determines a service to be provided to the communication terminal based on the answer information, and transmits to a relay device an operating parameter for controlling the relay device in transmitting or receiving content data to or from the communication terminal according to the determined service.Type: GrantFiled: August 5, 2015Date of Patent: July 10, 2018Assignee: Ricoh Company, Ltd.Inventors: Takeshi Horiuchi, Atsushi Nakafuji, Takahiro Asai, Yohei Yamamoto, Yoshikazu Goto
-
Patent number: 9890146Abstract: A compound represented by general formula (I) wherein all symbols are as defined in the specification, a salt or N-oxide of the compound, or a solvate or prodrug of the compound or the salt or N-oxide has a selective EP2 agonist activity and is highly safe, and is therefore useful as a drug, especially as a therapeutic agent for EP2 receptor-related diseases including immune diseases, allergic diseases, neuronal death, dysmenorrhea, premature birth, miscarriage, baldness, ocular diseases, erectile dysfunction, arthritis, lung injury, pulmonary fibrosis, pulmonary emphysema, bronchitis, chronic obstructive pulmonary disease, bone diseases, cartilage injury and others.Type: GrantFiled: February 26, 2015Date of Patent: February 13, 2018Assignee: ONO PHARMACEUTICAL CO., LTD.Inventors: Seiji Ogawa, Toshihide Watanabe, Isamu Sugimoto, Kousuke Tani, Kazumi Moriyuki, Yoshikazu Goto, Shinsaku Yamane
-
Patent number: 9648647Abstract: In one aspect of the present invention, a base station includes a reception unit configured to receive a call request or a paging response according to circuit switching from a mobile station; a packet switched communication state determination unit configured to determine a state of packet switched communication of the mobile station, when the call request or the paging response is received from the mobile station; and a circuit switching communication processing unit configured to establish a circuit switched bearer using a radio parameter for circuit switched communication, when no packet switched communication is performed in the mobile station.Type: GrantFiled: March 27, 2014Date of Patent: May 9, 2017Assignee: NTT DOCOMO, INC.Inventors: Tomoyasu Yoshikawa, Yoshikazu Goto
-
Publication number: 20170015657Abstract: A compound represented by general formula (I) wherein all symbols are as defined in the specification, a salt or N-oxide of the compound, or a solvate or prodrug of the compound or the salt or N-oxide has a selective EP2 agonist activity and is highly safe, and is therefore useful as a drug, especially as a therapeutic agent for EP2 receptor-related diseases including immune diseases, allergic diseases, neuronal death, dysmenorrhea, premature birth, miscarriage, baldness, ocular diseases, erectile dysfunction, arthritis, lung injury, pulmonary fibrosis, pulmonary emphysema, bronchitis, chronic obstructive pulmonary disease, bone diseases, cartilage injury and others.Type: ApplicationFiled: February 26, 2015Publication date: January 19, 2017Applicant: ONO PHARMACEUTICAL CO., LTD.Inventors: Seiji OGAWA, Toshihide WATANABE, Isamu SUGIMOTO, Kousuke TANI, Kazumi MORIYUKI, Yoshikazu GOTO, Shinsaku YAMANE
-
Patent number: 9479734Abstract: An information processing apparatus includes one or more processors configured to receive image data from another information processing apparatus. The processor includes a reception unit that receives call information from the other information processing apparatus when the processor is in a state of receiving at least the image data from the other information processing apparatus, and a calling sound output unit that outputs a calling sound upon reception of the call information by the reception unit.Type: GrantFiled: October 28, 2015Date of Patent: October 25, 2016Assignee: RICOH COMPANY, LTD.Inventors: Koichi Inoue, Takahiro Asai, Yoshikazu Goto
-
Publication number: 20160127688Abstract: An information processing apparatus includes one or more processors configured to receive image data from another information processing apparatus. The processor includes a reception unit that receives call information from the other information processing apparatus when the processor is in a state of receiving at least the image data from the other information processing apparatus, and a calling sound output unit that outputs a calling sound upon reception of the call information by the reception unit.Type: ApplicationFiled: October 28, 2015Publication date: May 5, 2016Inventors: Koichi INOUE, Takahiro ASAI, Yoshikazu GOTO
-
Patent number: 9320000Abstract: A base station in accordance with one embodiment of the present invention includes a cumulative value storage unit configured to store a cumulative value of transmission power control commands transmitted to a mobile station; a transmission power control command determination unit configured to determine a transmission power control command based on the cumulative value stored in the cumulative value storage unit, when uplink transmission power is initialized; and a control channel transmission unit configured to transmit the transmission power control command determined by the transmission power control command determination unit to the mobile station on a control channel.Type: GrantFiled: June 28, 2013Date of Patent: April 19, 2016Assignee: NTT DOCOMO, INC.Inventor: Yoshikazu Goto
-
Publication number: 20160044278Abstract: A communication management system transmits questionnaire information including a set of questions relating to one or more services available to a communication terminal to the communication terminal through a network, receives answer information including a set of answers to the set of questions from the communication terminal through the network, determines a service to be provided to the communication terminal based on the answer information, and transmits to a relay device an operating parameter for controlling the relay device in transmitting or receiving content data to or from the communication terminal according to the determined service.Type: ApplicationFiled: August 5, 2015Publication date: February 11, 2016Inventors: Takeshi HORIUCHI, Atsushi Nakafuji, Takahiro Asai, Yohei Yamamoto, Yoshikazu Goto
-
Publication number: 20160014822Abstract: In one aspect of the present invention, a base station includes a reception unit configured to receive a call request or a paging response according to circuit switching from a mobile station; a packet switched communication state determination unit configured to determine a state of packet switched communication of the mobile station, when the call request or the paging response is received from the mobile station; and a circuit switching communication processing unit configured to establish a circuit switched bearer using a radio parameter for circuit switched communication, when no packet switched communication is performed in the mobile station.Type: ApplicationFiled: March 27, 2014Publication date: January 14, 2016Applicant: NTT DOCOMO, INCInventors: Tomoyasu YOSHIKAWA, Yoshikazu GOTO
-
Publication number: 20150156735Abstract: A base station in accordance with one embodiment of the present invention includes a cumulative value storage unit configured to store a cumulative value of transmission power control commands transmitted to a mobile station; a transmission power control command determination unit configured to determine a transmission power control command based on the cumulative value stored in the cumulative value storage unit, when uplink transmission power is initialized; and a control channel transmission unit configured to transmit the transmission power control command determined by the transmission power control command determination unit to the mobile station on a control channel.Type: ApplicationFiled: June 28, 2013Publication date: June 4, 2015Applicant: NTT DOCOMO, INC.Inventor: Yoshikazu Goto
-
Publication number: 20150141070Abstract: A mobile station in accordance with one embodiment of the present invention includes a cumulative value storage unit configured to store a cumulative value of transmission power control commands transmitted from a base station; and a cumulative value addition unit configured to add the cumulative value stored in the cumulative value storage unit or a value calculated from the cumulative value to a predetermined initial value to calculate transmission power of a physical uplink shared channel or a physical uplink control channel, when uplink transmission power is initialized.Type: ApplicationFiled: June 26, 2013Publication date: May 21, 2015Applicant: NTT DOCOMO, INC.Inventor: Yoshikazu Goto
-
Publication number: 20150071148Abstract: A state-transition-timer setting system includes: an acquiring unit that acquires prediction information on a traffic amount of a mobile equipment; a timer determining unit that determines a state transition timer for a time after which a state of the mobile equipment transitions from a communication state to a power-saving state, based on the prediction information; and a timer setting unit that sets the state transition timer for the mobile equipment. The state transition timer includes either a time from when data communication of the mobile equipment is completed to when a transition request command to request transition into the power-saving state is transmitted to the base station, or a shortest transmission interval at which the mobile equipment can transmit the transition request command subsequently to when the mobile equipment transmits the transition request command after completion of data communication of the mobile equipment.Type: ApplicationFiled: April 24, 2013Publication date: March 12, 2015Applicant: NTT DOCOMO, INC.Inventors: Shinji Komatsu, Yoshikazu Goto